Cargando…
HIV-2 Protease resistance defined in yeast cells
BACKGROUND: Inhibitors of the HIV-1 Protease currently used in therapeutic protocols, have been found to inhibit, although at higher concentrations, the HIV-2 encoded enzyme homologue. Similar to observations in HIV-1 infected individuals, therapeutic failure has also been observed for some patients...
Autores principales: | M'Barek, Najoua Ben, Audoly, Gilles, Raoult, Didier, Gluschankof, Pablo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570497/ https://www.ncbi.nlm.nih.gov/pubmed/16956392 http://dx.doi.org/10.1186/1742-4690-3-58 |
Ejemplares similares
-
Involvement of a small GTP binding protein in HIV-1 release
por: Audoly, Gilles, et al.
Publicado: (2005) -
Cell Therapy for Retinal Dystrophies: From Cell Suspension Formulation to Complex Retinal Tissue Bioengineering
por: Ben M'Barek, Karim, et al.
Publicado: (2019) -
Deglycosylation of Tropheryma whipplei biofilm and discrepancies between diagnostic results during Whipple’s disease progression
por: Audoly, Gilles, et al.
Publicado: (2016) -
A fission yeast cell-based system for multidrug resistant HIV-1 proteases
por: Benko, Zsigmond, et al.
Publicado: (2017) -
Characterization of Mediterranean Durum Wheat for Resistance to Pyrenophora tritici-repentis
por: Laribi, Marwa, et al.
Publicado: (2022)